LONDON, February 7, 2017 /PRNewswire/ --
Jean-François Korobelnik, European Ophthalmic Review, 2016;10(2):125-31DOI: https://doi.org/10.17925/EOR.2016.10.02.125
(Logo: http://photos.prnewswire.com/prnh/20151014/276718LOGO )
Published recently in European Ophthalmic Review, the peer-reviewed journal from touchOPHTHALMOLOGY,
The full peer-reviewed, open-access article is available here:
Disclosure: Jean-Francois Korobelnik has been a consultant for Alcon, Alimera, Allergan, Bayer, Horus, Novartis, Roche, Théa and Zeiss.
Note to the Editor
touchOPHTHALMOLOGY (a division of Touch Medical Media) publishes the European Ophthalmic Review, a peer-reviewed, open access, bi-annual journal specialising in the publication of balanced and comprehensive review articles written by leading authorities to address the most important and salient developments in the field of ophthalmology. The aim of these reviews is to break down the high science from 'data-rich' primary papers and provide practical advice and opinion on how this information can help physicians in the day to day clinical setting. Practice guidelines, symposium write-ups, case reports, and original research articles are also featured to promote discussion and learning amongst physicians, clinicians, researchers and related healthcare professionals.
For inquires please contact:
Nicola Cartridge - Managing Editor
Providing practical opinion to support best practice for busy healthcare professionals.
Subscribe to our Free Newsletters!
Some drugs or therapeutic agents cause undesirable reactions in lungs, known as drug-induced ...
Sleep disorders are collectively known as ''Somnipathy.'' There are over 70 different medically ...
Unintended pregnancies are very common these days, and so one in about four pregnant women go for ...View All